The Sad Truth
Alzheimer’s and dementia-related illnesses are leading causes of death in the United States. Instead of moving closer to a cure, we are moving closer to the disease with a new person being diagnosed every 65 seconds.
Alzheimer’s is the only top-10 cause of death in the United States with NO cure, means of prevention, or treatment to modify the disease. Approximately 5.7 million people in the U.S. currently have Alzheimer’s disease or a dementia-related illness. The number of Americans with Alzheimer’s is projected to triple to 16 million by 2050.
A cure needs to be identified. NOW!
IN ASSOCIATION WITH
Current Donor Options
“I would like to sincerely thank AlzOut for donating to my lab to help purchase equipment, namely a ‘MESO QuickPlex SQ 120’, to measure biomarkers of Alzheimer’s disease. Alzheimer’s disease steals the minds of millions and robs time from families with their loved ones. This equipment will aid greatly in helping us determine root causes of Alzheimer’s disease and ways to prevent AD in the future.”
“I would like to give a special acknowledgement to Johnny Weir for selflessly raising funds for AlzOut. I was a competitive figure skater from childhood through my late teens, so I am honored and excited to think that he has made an indirect contribution to our Alzheimer’s research!”
“As an early career investigator in the field of Exercise Physiology, I am incredibly thankful for the financial support from AlzOut to purchase a state-of-the-art multiplex. It is truly my belief that exercise is medicine and that physical activity can play a significant role in delaying, if not preventing, the onset of numerous diseases including Alzheimer’s and related dementias. Adding the multiplex instrument to our tool kit has allowed us to ask more in-depth questions as well as to seek mechanistic links between exercise and age-related cognitive decline. With these newly garnered abilities, I am most excited to contribute to the currently known findings pertaining to exercise and brain health, especially in populations that have been historically excluded from prominent biomedical research trials. Therefore, the contribution of AlzOut has not only accentuated our research capabilities, but ultimately, they have extended our reach into our communities, which will undoubtedly translate into a lasting impact.”
“Thank you, AlzOut, for helping to fund our lab’s purchase of a multiplex instrument! This equipment will allow us to investigate biomarker changes in Alzheimer’s disease biofluids such as plasma and cerebrospinal fluid.”
“The Nelson lab is so grateful for AlzOut’s generous donation, which equipped the lab with a plate reader necessary to measure key biomarkers of Alzheimer’s disease. Your donation will ultimately support cutting-edge efforts to understand how Alzheimer’s disease develops and how to more effectively treat the causes and symptoms of this widespread disease affecting more than 6 million Americans. Furthermore, this plate reader will allow us to collaborate on projects outside of our lab, increasing awareness of our research and Alzheimer’s in the scientific community. Without support like yours, further understanding Alzheimer’s disease would not be possible, so we would like to thank you again for your support of our research that could benefit millions.”
“On behalf of the entire Nelson Lab, we want to sincerely thank AlzOut for their donation to our lab. We are primarily focused on determining causes of Alzheimer’s disease. With the funding generously provided by AlzOut, we purchased a MESO QuickPlex SQ 120. This multiplex plate reader will allow us to measure proteins such as amyloid-beta and tau as well as proinflammatory cytokines and other molecules associated with Alzheimer’s disease. We are incredibly thankful for AlzOut’s financial support for this important work.”
“We’re extremely thankful to AlzOut for their donation to the Nelson Lab! With the donation, we purchased a MESO QuickPlex SQ 120. This device will let us measure amyloid-beta, tau, proinflammatory cytokines, and other biomarkers linked to Alzheimer’s disease, providing data necessary to determine if an association between these biomarkers and infections exists.”
Latest News
AlzOut donates to UCSF for Dr. Julio C. Rojas’ research focused on experimental therapeutics in Alzheimer’s disease
Dr. Julio C. Rojas is an associate professor of Neurology at the University of California,
AlzOut Researchers Gain National Recognition
Amy R. Nelson, Ph.D., has devoted more than a decade to researching Alzheimer’s disease, educating
Alzheimer’s and Covid 19: Virtual Town Hall
AlzOut and Dr. Hussein Yassine, a leading researcher at Keck Medicine of USC, explore the
ALZOUT Donates to the Yassine Lab
We are very thankful for ALZOUT for their support of the Yassine Lab. In 2019,